Alternatively activated macrophages; a double-edged sword in allergic asthma

Abstract

Background: Macrophages are heterogenous phagocytic cells with an important role in the innate immunity. They are, also, significant contributors in the adaptive immune system. Macrophages are the most abundant immune cells in the lung during allergic asthma, which is the most common chronic respiratory disease of both adults and children. Macrophages activated by Th1 cells are known as M1 macrophages while those activated by IL-4 and IL-13 are called alternatively activated macrophages (AAM) or M2 cells. AAM are subdivided into four distinct subtypes (M2a, M2b, M2c and M2d), depending on the nature of inducing agent and the expressed markers. Body: IL-4 is the major effector cytokine in both alternative activation of macrophages and pathogenesis of asthma. Thus, the role of M2a macrophages in asthma is a major concern. However, this is controversial. Therefore, further studies are required to improve our knowledge about the role of IL-4-induced macrophages in allergic asthma, through precisive elucidation of the roles of specific M2a proteins in the pathogenesis of asthma. In the current review, we try to illustrate the different functions of M2a macrophages (protective and pathogenic roles) in the pathogenesis of asthma, including explanation of how different M2a proteins and markers act during the pathogenesis of allergic asthma. These include surface markers, enzymes, secreted proteins, chemokines, cytokines, signal transduction proteins and transcription factors. Conclusions: AAM is considered a double-edged sword in allergic asthma. Finally, we recommend further studies that focus on increased selective expression or suppression of protective and pathogenic M2a markers.

Allogeneic adipose-derived stem cells promote ischemic muscle repair by inducing M2 macrophage polarization via the HIF-1α/IL-10 pathway

“…M2 macrophages, as the anti‐inflammatory phenotype, could contribute to muscle repair through resolving inflammation, promoting angiogenesis, stimulating myogenesis, and fiber growth 47,48 . Based on activating stimulus, M2 macrophages can be further divided into four alternately activated subtypes: M2a (induced by exposure to IL‐4 or IL‐13); M2b (activated by immune complexes in the presence of a Toll‐like receptor ligand); M2c (stimulated with IL‐10, glucocorticoids, or TGF‐β); M2d (elicited by Toll‐like receptors [TLR] agonists through the adenosine receptor) 21,49 . The macrophages in mice treated with ASCs expressing a high level of Arg‐1, similar to M2c subset, which is characterized by high expression of Arg‐1 and IL‐10 50 .…”

The Role of T Cells and Macrophages in Asthma Pathogenesis: A New Perspective on Mutual Crosstalk

“…M2 macrophages have the lower expression of MHC class II molecules and CD86 as well as the higher expression of macrophage mannose receptor (MRC) 1, arginase (Arg) 1, CD206, and CD163, modulating eosinophilic infiltration in type 2 inflammation [ 79 ]. They are prominent in parasite immunomodulation, tissue remodeling, and Th2 cell differentiation [ 80 ]. Melgert et al [ 81 ] observed that M2 macrophages were abundant in the BALF of asthmatic patients.…”

Could Arachidonic Acid-Derived Pro-Resolving Mediators Be a New Therapeutic Strategy for Asthma Therapy?

“…Macrophages are classified into classical (M1) or alternative activation (M2a, M2b, M2c, or M2d subtypes). During allergic asthma, under exposure to Th2 cytokines (IL-4 and IL-13), macrophages are reprogrammed to M2a profile and perform diverse functions ranging between protective and pathogenic roles (6)(7)(8)(9). Airway remodelling is another key feature of asthma pathogenesis and can precede the development of inflammation (10).…”